Prepared For

Mr Suresh Chandra Verma

M 60
fa lse

Name Gender Your Health Summary

Mr Suresh Chandra Verma M Understand Your Health At A Glance
Your Personalized Health Summary is Now Available.
Patient ID Age
15501765 60 View Detailed Summary on our App

Your Health at a Glance – A Personalized Journey

Report Sections

Body Summary
1
A visual snapshot of your overall health, simple and easy to understand

Quick Health Highlights

2
Your health scores and a single view of all abnormal results for quick attention

Lab Report Overview

3
Understand at a glance which tests are normal and which are abnormal

Personalized Health Advisory

4
Actionable insights and expert guidance tailored just for you

Doctor's Reference Report

5
Complete lab results with interpretations to share with your healthcare provider

How to Read This Report

This comprehensive health report provides detailed insights into your test results. Each section offers different perspectives on your
health status, from visual summaries to detailed analysis and personalized recommendations.
fa lse

Name Gender Your Health Summary

Mr Suresh Chandra Verma M Understand Your Health At A Glance
Your Personalized Health Summary is Now Available.
Patient ID Age
15501765 60 View Detailed Summary on our App

All In Range Borderline Out Of Range

Health Summary

THYROID PROFILE

Everything looks good

CARDIAC PROFILE
DIABETES MONITORING
Test Name Result
Test Name Result
Triglycerides 249.2
HbA1c (Glycosylated
HDL Cholesterol 26.9 5.7
Haemoglobin)
Non HDL Cholesterol 136.1 Blood Sugar (Fasting) 144.0

+ 3 tests Please Watchout Please Watchout

KIDNEY PROFILE

Test Name Result

LIVER PROFILE
Bun/Creatinine Ratio 10.49

Urea / Creatinine Ratio 22.44 Everything looks good

Please Watchout

ELECTROLYTES
ANEMIA STUDIES
Everything looks good
Everything looks good

VITAMIN PROFILE

Test Name Result

Vitamin D 25 - Hydroxy 24.32

Please Watchout

Note: This section offers a quick snapshot of selected parameters. For all parameters and detailed analysis with clinical interpretation, please refer to the following
pages

View Report on App

Page 1 of 7
fa lse

Name Gender Your Health Summary

Mr Suresh Chandra Verma M Understand Your Health At A Glance
Your Personalized Health Summary is Now Available.
Patient ID Age
15501765 60 View Detailed Summary on our App

Quick Health Summary

Personal Insights - Health Score

71
Overall, most parameters are within normal ranges, indicating good general health. The Diabetes and
Cardiac Health profiles may affect energy levels and heart function, so consider maintaining a balanced diet
and regular physical activity. Incorporate a variety of fruits, vegetables, and whole grains into your meals,
engage in activities like walking or yoga, and schedule routine check-ups to stay proactive about your
health. Remember, small consistent changes can lead to meaningful improvements over time.
Note - Higher scores tentatively indicate better health status

Summary of Key Health Indicators

Total Parameters Tested Borderline Results Out Of Range Results

94 7 6

Health Status by Body System

Out of
Profile Total Borderline Key Results
Range
Triglycerides (249.2)

Cardiac Profile 9 1 5 HDL Cholesterol (26.9)

VLDL (49.84)

Blood Sugar (Fasting) (144.0)

Diabetes Monitoring 4 1 1
HbA1c (Glycosylated Haemoglobin) (5.7)

Inflammation 1 0 0 All In Range

Iron 4 1 0 Iron (61.8)

Vitamin Profile 1 1 0 Vitamin D (25-Hydroxy) (24.32)

Thyroid Profile 3 0 0 All In Range

Blood Disorder 17 0 0 All In Range

Anemia Studies 8 0 0 All In Range

Infectious Diseases 6 0 0 All In Range

Liver Profile 15 0 0 All In Range

Page 2 of 7
fa lse

Out of
Profile Total Borderline Key Results
Range
BUN : Creatinine ratio (10.49)
Kidney Profile 10 2 0
Urea : Creatinine ratio (22.44)

Urinalysis 12 1 0 Uric Acid (7.6)

Electrolytes 4 0 0 All In Range

Page 3 of 7
fa lse

Name Gender Your Health Summary

Mr Suresh Chandra Verma M Understand Your Health At A Glance
Your Personalized Health Summary is Now Available.
Patient ID Age
15501765 60 View Detailed Summary on our App

Report Summary In Range Borderline Out Of Range No color - Reference range not available

INFLAMMATION
Test Name Result unit Range
ESR - Erythrocyte Sedimentation Rate 14 mm/hr < 14

IRON
Test Name Result unit Range
Iron 61.8 µg/dL 65 - 175
TIBC,(Total Iron Binding Capacity) 278 µg/dL 250 - 450
UIBC 216.2 µg/dL 69 - 240
Transferrin Saturation 22.23 % 14 - 50

VITAMIN PROFILE
Test Name Result unit Range
Vitamin D 25 - Hydroxy 24.32 ng/mL 30 - 100

THYROID PROFILE
Test Name Result unit Range
Triiodothyronine (T3) 1.28 ng/ml 0.71 - 2.01
Total Thyroxine (T4) 9.37 µg/dL 4.87 - 11.2
Thyroid Stimulating Hormone (Ultrasensitive) 3.62 mIU/L 0.35 - 4.94

Page 4 of 7
fa lse

Name Gender Your Health Summary

Mr Suresh Chandra Verma M Understand Your Health At A Glance
Your Personalized Health Summary is Now Available.
Patient ID Age
15501765 60 View Detailed Summary on our App

Report Summary In Range Borderline Out Of Range No color - Reference range not available

BLOOD DISORDER
Test Name Result unit Range
Hemoglobin 13.6 g/dL 13 - 17
TLC 6.3 10^3/µl 4 - 10
Neutrophils 51 % 40 - 80
Lymphocytes 40 % 20 - 40
Monocytes 7% 2 - 10
Eosinophils 2% 1-6
Basophils 0% <2
Neutrophils. 3.21 10^3/µl 2-7
Lymphocytes. 2.52 10^3/µl 1-3
Monocytes. 0.44 10^3/µl 0.2 - 1
Eosinophils. 0.13 10^3/µl 0.02 - 0.5
Basophils. 0 10^3/µl < 0.5
Platelet Count 196 10^3/µl 150 - 410
Mean Platelet Volume (MPV) 10.6 fL 9.3 - 12.1
PDW 15.2 fL 8.3 - 25
P-LCR 31 % 18 - 50
P-LCC 61 10^9/L 44 - 140

ANEMIA STUDIES
Test Name Result unit Range
RBC Count 5.0 10^6/µl 4.5 - 5.5
PCV 42.7 % 40 - 50
MCV 86.3 fl 83 - 101
MCH 27.6 pg 27 - 32
MCHC 31.9 g/dL 31.5 - 34.5
RDW (CV) 13.6 % 11.6 - 14
RDW-SD 42.3 fl 35.1 - 43.9
Mentzer Index 17.26 %

INFECTIOUS DISEASES
Test Name Result unit Range
PCT 0.2 % 0.17 - 0.32
Deposit Absent
Leucocyte esterase Negative
Pus Cells (WBCs) 1-2 /hpf
Yeast Cells Absent
Protozoa Absent

Page 5 of 7
fa lse

Name Gender Your Health Summary

Mr Suresh Chandra Verma M Understand Your Health At A Glance
Your Personalized Health Summary is Now Available.
Patient ID Age
15501765 60 View Detailed Summary on our App

Report Summary In Range Borderline Out Of Range No color - Reference range not available

DIABETES MONITORING
Test Name Result unit Range
Glycosylated Hemoglobin (HbA1c) 5.7 % < 5.6
Estimated Average Glucose 116.89 mg/dL
Glucose Fasting 144.0 mg/dL 70 - 100
Urine Glucose (sugar) Negative

LIVER PROFILE
Test Name Result unit Range
Bilirubin Total 0.4 mg/dL < 1.2
Bilirubin Direct 0.2 mg/dL < 0.5
Bilirubin Indirect 0.2 mg/dL <1
SGOT/AST 15.8 U/L 5 - 34
SGPT/ALT 18.0 U/L < 55
SGOT/SGPT Ratio 0.88 %
Alkaline Phosphatase 85.0 U/L 40 - 150
Total Protein 7.2 g/dL 6.4 - 8.3
Albumin 4.2 gm/dL 3.8 - 5
Globulin 3 g/dL 2.3 - 3.5
Albumin :Globulin Ratio 1.4 < 2.1
Gamma Glutamyl Transferase (GGT) 23.2 U/L < 64
Calcium Serum 9.5 mg/dL 8.8 - 10
Bilirubin Urine Negative
Urobilinogen Normal

KIDNEY PROFILE
Test Name Result unit Range
Blood Urea 20.2 mg/dL 18 - 55
Bun 9.44 mg/dL 8.4 - 25.7
Creatinine 0.9 mg/dL 0.72 - 1.25
eGFR (CKD-EPI) 97.75 ml/min/1.73 sq m
Bun/Creatinine Ratio 10.49 12 - 20
Urea / Creatinine Ratio 22.44 25.68 - 42.8
Urine Protein (Albumin) Negative
Blood Negative
Crystals Absent
Cast Absent

Page 6 of 7
fa lse

Name Gender Your Health Summary

Mr Suresh Chandra Verma M Understand Your Health At A Glance
Your Personalized Health Summary is Now Available.
Patient ID Age
15501765 60 View Detailed Summary on our App

Report Summary In Range Borderline Out Of Range No color - Reference range not available

URINALYSIS
Test Name Result unit Range
Uric Acid 7.6 mg/dL 3.5 - 7.2
Volume 20 mL
Colour Pale yellow
Transparency Clear
Reaction (pH) 6.0 4.5 - 8
Specific Gravity 1.015 1.01 - 1.03
Urine Ketones (Acetone) Negative
Nitrite Negative
Epithelial Cells 1-2 /hpf
Red blood Cells Absent /hpf
Amorphous deposits Absent
Bacteria Absent

ELECTROLYTE PROFILE
Test Name Result unit Range
Phosphorus 3.5 mg/dL 2.3 - 4.7
Sodium 136.5 mmol/L 136 - 145
Potassium 4.1 mmol/L 3.5 - 5.1
Chloride 105.6 mmol/L 98 - 107

CARDIAC PROFILE
Test Name Result unit Range
Total Cholesterol 163.0 mg/dL < 200
Triglycerides 249.2 mg/dL < 150
HDL Cholesterol 26.9 mg/dL 40 - 80
Non HDL Cholesterol 136.1 mg/dL < 130
LDL Cholesterol 86.26 mg/dL 30 - 100
V.L.D.L Cholesterol 49.84 mg/dL < 30
Chol/HDL Ratio 6.06 Ratio 3.5 - 5
HDL/ LDL Ratio 0.31 Ratio 0.5 - 3
LDL/HDL Ratio 3.21 Ratio

Page 7 of 7
fa lse

Name Gender Your Health Summary

Mr Suresh Chandra Verma M Understand Your Health At A Glance
Your Personalized Health Summary is Now Available.
Patient ID Age
15501765 60 View Detailed Summary on our App

Health Advisory
In Range Borderline (BL) Out Of Range

Iron
Iron is an essential mineral that helps in the formation of hemoglobin, which carries oxygen in the blood. Iron tests
are performed to evaluate iron deficiency, anemia, and conditions related to iron overload.

Iron: 61.8 µg/dL BORDERLINE

LOW NORMAL HIGH

< 65 65-175 > 175

You: 61.8

Vitamins Profile
Vitamins are considered essential nutrients because they perform hundreds of roles in your body. They help
maintain bones, heal wounds, and strengthen your immune system. They also convert food into energy, and repair
cellular damage

Vitamin D 25 - Hydroxy: 24.32 ng/mL BORDERLINE

LOW NORMAL HIGH

< 30 30-100 > 100

You: 24.32

Diabetes
This panel is used to check how much glucose/sugar there is in your blood. Too much blood glucose might
indicate diabetes.

Glycosylated Hemoglobin (HbA1c): 5.7 % BORDERLINE

NORMAL HIGH

< 5.6 > 5.6

You: 5.7
fa lse

Glucose Fasting: 144.0 mg/dL OUT OF RANGE

LOW NORMAL HIGH

< 70 70-100 > 100

You: 144

Urinalysis
The urinalysis, as it's sometimes called, is a set of tests conducted on your urine - these tests measure specific
properties of urine and also find out if there are any unwanted chemicals in your urine. If your results in these tests
are abnormal, your doctor can correlate them clinically. Sometimes, abnormal urine results are because of kidney
disease, liver disease or diabetes.

Uric Acid: 7.6 mg/dL BORDERLINE

LOW NORMAL HIGH

< 3.5 3.5-7.2 > 7.2

You: 7.6

Cardiac Profile
Most people believe they are safe from heart diseases, but in reality, heart diseases are the leading cause of death
in the world. There are many different forms of heart disease. Narrowing or blockage of the coronary arteries is the
most common cause of heart disease, which are the vessels that supply blood to the heart. This is called coronary
artery disease and it occurs slowly over time. It is the main cause of heart attacks.

Triglycerides: 249.2 mg/dL OUT OF RANGE

NORMAL HIGH

< 150 > 150

You: 249.2

HDL Cholesterol: 26.9 mg/dL OUT OF RANGE

LOW NORMAL HIGH

< 40 40-80 > 80

You: 26.9
 Patient NAME : Mr Suresh Chandra Verma
DOB/Age/Gender : 60 Y/Male Report STATUS : Final Report
Patient ID / UHID : 15501765/RCL15402454 Barcode NO : 31578125
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Feb 13, 2026, 07:16 AM Report Date : Feb 13, 2026, 02:21 PM.
Test Description Value(s) Unit(s) Reference Range

Fit India Full Body Checkup - Essential

Complete Blood Count (CBC)

RBC Parameters
Hemoglobin 13.6 g/dL 13.0 - 17.0
Cyanide-free colorimetry
RBC Count 5.0 10^6/µl 4.5 - 5.5
Electrical impedance
PCV 42.7 % 40 - 50
Calculated
MCV 86.3 fl 83 - 101
Direct Measure Impendence
MCH 27.6 pg 27 - 32
Calculated
MCHC 31.9 g/dL 31.5 - 34.5
Calculated
RDW (CV) * 13.6 % 11.6 - 14.0
Calculated
RDW-SD * 42.3 fl 35.1 - 43.9
Calculated
WBC Parameters
TLC 6.3 10^3/µl 4 - 10
Electrical impedance and microscopy
Differential Leucocyte Count
Neutrophils 51 % 40-80
Flowcytometry
Lymphocytes 40 % 20-40
Flowcytometry
Monocytes 7 % 2-10
Flowcytometry
Eosinophils 2 % 1-6
Flowcytometry
Basophils 0 % <2
Flowcytometry
Absolute Leukocyte Counts
Calculated
Neutrophils. 3.21 10^3/µl 2-7
Lymphocytes. 2.52 10^3/µl 1-3
Monocytes. 0.44 10^3/µl 0.2 - 1.0
Eosinophils. 0.13 10^3/µl 0.02 - 0.5
Basophils. 0 10^3/µl 0.02 - 0.5
Platelet Parameters
Platelet Count 196 10^3/µl 150 - 410
Electrical impedance and microscopy
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Seva Pathology, 12/475, Ultra Tower, Macrobert Ganj, Near Shani
Dev Mandir, Kanpur (UP)

Page 1 of 15
 Patient NAME : Mr Suresh Chandra Verma
DOB/Age/Gender : 60 Y/Male Report STATUS : Final Report
Patient ID / UHID : 15501765/RCL15402454 Barcode NO : 31578125
Referred BY : Self Sample Type : Whole blood EDTA
Sample Collected : Feb 13, 2026, 07:16 AM Report Date : Feb 13, 2026, 02:21 PM.
Test Description Value(s) Unit(s) Reference Range
Mean Platelet Volume (MPV) * 10.6 fL 9.3 - 12.1
Calculated
PCT * 0.2 % 0.17 - 0.32
Calculated
PDW * 15.2 fL 8.3 - 25.0
Calculated
P-LCR * 31 % 18 - 50
Calculated
P-LCC * 61 10^9/L 44 - 140
Calculated
Mentzer Index * 17.26 % > 13
Calculated

Interpretation:
CBC provides information about red cells, white cells and platelets. Results are useful in the diagnosis of anemia, infections, leukemias, clotting disorders and many
other medical conditions.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Seva Pathology, 12/475, Ultra Tower, Macrobert Ganj, Near Shani
Dev Mandir, Kanpur (UP)

Page 2 of 15
 Patient NAME : Mr Suresh Chandra Verma
DOB/Age/Gender : 60 Y/Male Report STATUS : Final Report
Patient ID / UHID : 15501765/RCL15402454 Barcode NO : 31578125
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Feb 13, 2026, 07:16 AM Report Date : Feb 13, 2026, 02:52 PM.
Test Description Value(s) Unit(s) Reference Range

Erythrocyte Sedimentation Rate (ESR)

ESR - Erythrocyte Sedimentation Rate 14 mm/hr 0 - 14

MODIFIED WESTERGREN

Interpretation:
ESR is also known as Erythrocyte Sedimentation Rate. An ESR test is used to assess inflammation in the body. Many conditions can cause
an abnormal ESR, so an ESR test is typically used with other tests to diagnose and monitor different diseases. An elevated ESR may occur in
inflammatory conditions including infection, rheumatoid arthritis ,systemic vasculitis, anemia, multiple myeloma , etc. Low levels are typically
seen in congestive heart failure, polycythemia ,sickle cell anemia, hypo fibrinogenemia , etc.

Reference- Dacie and lewis practical hematology

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Seva Pathology, 12/475, Ultra Tower, Macrobert Ganj, Near Shani
Dev Mandir, Kanpur (UP)

Page 3 of 15
 Patient NAME : Mr Suresh Chandra Verma
DOB/Age/Gender : 60 Y/Male Report STATUS : Final Report
Patient ID / UHID : 15501765/RCL15402454 Barcode NO : 31578125
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Feb 13, 2026, 07:16 AM Report Date : Feb 13, 2026, 04:00 PM.
Test Description Value(s) Unit(s) Reference Range

HbA1C (Glycosylated Haemoglobin)

Glycosylated Hemoglobin (HbA1c) 5.7 H* % < 5.7

HPLC
Estimated Average Glucose * 116.89 mg/dL Refer Table Below

Interpretation:
Interpretation For HbA1c% As per American Diabetes Association (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years <5.7
At risk (Prediabetes) 5.7 - 6.4
Diagnosing Diabetes >= 6.5
Age > 19 years
Goal of therapy: < 7.0
Therapeutic goals for glycemic control
Age < 19 years
Goal of therapy: <7.5

Note:
1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still have a high
concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled.
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular disease. In patients with
significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 % may not be appropriate.

Comments :
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term glycemic control as compared to blood
and urinary glucose determinations ADA criteria for correlation between HbA1c & Mean plasma glucose levels.
HbA1c(%) Mean Plasma Glucose (mg/dL) HbA1c(%) Mean Plasma Glucose (mg/dL)
6 126 12 298
8 183 14 355
10 240 16 413

Note :- (H* - High , L* - Low ,CL* - Critical Low,CH* - Critical High)

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Seva Pathology, 12/475, Ultra Tower, Macrobert Ganj, Near Shani
Dev Mandir, Kanpur (UP)

Page 4 of 15
 Patient NAME : Mr Suresh Chandra Verma
DOB/Age/Gender : 60 Y/Male Report STATUS : Final Report
Patient ID / UHID : 15501765/RCL15402454 Barcode NO : 31286175
Referred BY : Self Sample Type : FLUORIDE F
....

Sample Collected : Feb 13, 2026, 07:16 AM Report Date : Feb 13, 2026, 01:57 PM.
Test Description Value(s) Unit(s) Reference Range

Glucose Fasting

Glucose Fasting 144.0 H* mg/dL 70 - 100

GOD-POD

Note:-Kindly correlate clinically.

Interpretation:
Status Fasting plasma glucose in mg/dL
Normal 70 - 100
Impaired fasting glucose 101 - 125
Diabetes ≥126

Reference : American Diabetes Association

Comment :
Blood glucose determinations in commonly used as an aid in the diagnosis and treatment of diabetes. Elevated glucose levels
(hyperglycemia) may also occur with pancreatic neoplasm, hyperthyroidism, and adrenal cortical hyper function as well as other disorders.
Decreased glucose levels (hypoglycemia) may result from excessive insulin therapy insulinoma, or various liver diseases.

Note
[Link] diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL or a random / 2 hour plasma glucose value of > or = 200
mg/dL with symptoms of diabetes mellitus.
[Link] high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis.

Note :- (H* - High , L* - Low ,CL* - Critical Low,CH* - Critical High)

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Seva Pathology, 12/475, Ultra Tower, Macrobert Ganj, Near Shani
Dev Mandir, Kanpur (UP)

Page 5 of 15
 Patient NAME : Mr Suresh Chandra Verma
DOB/Age/Gender : 60 Y/Male Report STATUS : Final Report
Patient ID / UHID : 15501765/RCL15402454 Barcode NO : 30363599
Referred BY : Self Sample Type : Serum
....

Sample Collected : Feb 13, 2026, 07:16 AM Report Date : Feb 13, 2026, 02:47 PM.
Test Description Value(s) Unit(s) Reference Range

Liver Function Test (LFT)

Bilirubin Total 0.4 mg/dL 0.2 - 1.2

DIAZO
Bilirubin Direct 0.2 mg/dL 0.0 - 0.5
Diazo Reaction
Bilirubin Indirect * 0.2 mg/dL 0.1 - 1.0
Calculation (T Bil - D Bil)
SGOT/AST 15.8 U/L 5 - 34
IFCC without P5P
SGPT/ALT 18.0 U/L 0 to 55
IFCC without P5P
SGOT/SGPT Ratio * 0.88 - -
Alkaline Phosphatase 85.0 U/L 40 - 150
p-nitrophenyl Phosphate, AMP buffer
Total Protein 7.2 g/dL 6.4 - 8.3
Biuret
Albumin 4.2 gm/dL 3.8 - 5.0
BCG
Globulin * 3 g/dL 2.3 - 3.5
Calculation (T.P - Albumin)
Albumin :Globulin Ratio * 1.4 - 1.0 - 2.1
Calculation (Albumin/Globulin)
Gamma Glutamyl Transferase (GGT) * 23.2 U/L 12 - 64
ENZYMATIC

Interpretation:
The liver filters blood, metabolizes nutrients, detoxifies harmful substances, and produces blood clotting proteins. Liver cells contain enzymes that facilitate
these functions. When cells are damaged, enzymes leak into the blood, detectable through blood tests.

Key enzymes tested:

1. AST (SGOT): may indicate tissue injury / damage in muscles or liver.

2. ALT (SGPT): Primarily in the liver. Elevated ALT and AST suggest liver damage.
3. Alkaline Phosphatase & GGT: Linked to bile production and flow. Elevated levels may indicate bile flow issues related to the liver, gallbladder, or bile ducts.

Blood proteins, albumin and globulin, are essential for growth, development, and health.

1. Low protein: May indicate bleeding, liver disorders, malnutrition, or agammaglobulinemia.

2. High protein (Hyperproteinemia): Often due to dehydration or increased protein production.
3. Low albumin: Caused by poor diet, kidney, or liver disease.
4. High albumin: Usually due to severe dehydration.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Seva Pathology, 12/475, Ultra Tower, Macrobert Ganj, Near Shani
Dev Mandir, Kanpur (UP)

Page 6 of 15
 Patient NAME : Mr Suresh Chandra Verma
DOB/Age/Gender : 60 Y/Male Report STATUS : Final Report
Patient ID / UHID : 15501765/RCL15402454 Barcode NO : 30363599
Referred BY : Self Sample Type : Serum
....

Sample Collected : Feb 13, 2026, 07:16 AM Report Date : Feb 13, 2026, 02:47 PM.
Test Description Value(s) Unit(s) Reference Range

Kidney Function Test (KFT)

Blood Urea 20.2 mg/dL 18 - 55

Urease GLDH
Bun * 9.44 mg/dL 8.4 - 25.7
Urease
Creatinine 0.9 mg/dL 0.72 - 1.25
Enzymatic (Creatinase and Sarcosine Oxidase)
eGFR (CKD-EPI) * 97.75 ml/min/1.73 sq m Normal Or High: >= 90

Mild Or Decrease: 60-89

Mild To Moderate Decrease:

45-59

Mild To Severe Decrease:

30-44

Severe Decrease: 15-29

Kidney Failure: < 15

Bun/Creatinine Ratio * 10.49 L* 12 - 20
Calculated
Urea / Creatinine Ratio * 22.44 L* 25.68- 42.8
Calculated
Uric Acid 7.6 H* mg/dL 3.5 - 7.2
Uricase
Calcium Serum 9.5 mg/dL 8.8 - 10.0
Arsenazo III
Phosphorus 3.5 mg/dL 2.3 - 4.7
Ammonium Molybdate UV
Sodium 136.5 mmol/L 136 - 145
Direct ISE
Potassium 4.1 mmol/L 3.5 - 5.1
Direct ISE
Chloride 105.6 mmol/L 98 - 107
Direct ISE

Interpretation:
Kidney function tests is a collective term for a variety of individual tests and procedures that can be done to evaluate how well the kidneys are functioning. Many
conditions can affect the ability of the kidneys to carry out their vital functions. Some lead to a rapid (acute) decline in kidney function others lead to a gradual
(chronic) decline in function. Both result in a buildup of toxic waste substances done on urine samples, as well as on blood samples. A number of symptoms may indicate
a problem with your kidneys. These include : high blood pressure, blood in urine, frequent urges to urinate, difficulty beginning urination, painful urination, swelling in
the hands and feet due to a buildup of fluids in the body. A single symptom may not mean something serious. However, when occurring simultaneously, these symptoms
suggest that your kidneys are not working properly. Kidney function tests can help determine the reason. Ionized calcium this test if you have signs of kidney or
parathyroid disease. The test may also be done to monitor progress and treatment of these diseases."eGFR test is applicable for patients aged 18 years or more."

Note :- (H* - High , L* - Low ,CL* - Critical Low,CH* - Critical High)

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Seva Pathology, 12/475, Ultra Tower, Macrobert Ganj, Near Shani
Dev Mandir, Kanpur (UP)

Page 7 of 15
 Patient NAME : Mr Suresh Chandra Verma
DOB/Age/Gender : 60 Y/Male Report STATUS : Final Report
Patient ID / UHID : 15501765/RCL15402454 Barcode NO : 30363599
Referred BY : Self Sample Type : Serum
....

Sample Collected : Feb 13, 2026, 07:16 AM Report Date : Feb 13, 2026, 02:47 PM.
Test Description Value(s) Unit(s) Reference Range

Lipid Profile

Total Cholesterol 163.0 mg/dL <200

CHOD-PAP
Triglycerides 249.2 H* mg/dL <150
GPO-POD
HDL Cholesterol 26.9 L* mg/dL >40
CHOD & CHER
Non HDL Cholesterol * 136.1 H* mg/dL <130
Calculated
LDL Cholesterol * 86.26 mg/dL <100
Calculated
V.L.D.L Cholesterol * 49.84 H* mg/dL < 30
Calculated
Chol/HDL Ratio * 6.06 H* Ratio 3.5 - 5.0
Calculated
HDL/ LDL Ratio * 0.31 L* Ratio 0.5 - 3.0
Calculated
LDL/HDL Ratio * 3.21 Ratio -
Calculated

Interpretation:
Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation. NCEP recommends of 3
different samples to be drawn at intervals of 1 week for harmonizing biological variables that might be encountered in single assays.

National Lipid Association Recommendations Total Cholesterol Triglyceride LDL Cholesterol Non HDL Cholesterol
(NLA-2014) (mg/dL) (mg/dL) (mg/dL) (mg/dL)
Optimal <200 <150 <100 <130

Above Optimal 100-129 130 - 159

Borderline High 200-239 150-199 130-159 160 - 189
High >=240 200-499 160-189 190 - 219
Very High - >=500 >=190 >=220

HDL Cholesterol
Low High
<40 >=60

Risk Stratification for ASCVD (Atherosclerotic Cardiovascular Disease) by Lipid Association of India.

Risk Category A. CAD with > 1 feature of high risk group

B. CAD with >1 feature of very high risk group of recurrent ACS (within 1 year) despite LDL-C <or = 50 mg/dl
Extreme risk group
or poly vascular disease
[Link] ASCVD [Link] with 2 major risk factors of evidence of end organ
Very High Risk
damage 3. Familial Homozygous Hypercholesterolemia
1. Three major ASCVD risk factors 2. Diabetes with 1 major risk factor or no evidence

Note :- (H* - High , L* - Low ,CL* - Critical Low,CH* - Critical High)

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Seva Pathology, 12/475, Ultra Tower, Macrobert Ganj, Near Shani
Dev Mandir, Kanpur (UP)

Page 8 of 15
 Patient NAME : Mr Suresh Chandra Verma
DOB/Age/Gender : 60 Y/Male Report STATUS : Final Report
Patient ID / UHID : 15501765/RCL15402454 Barcode NO : 30363599
Referred BY : Self Sample Type : Serum
Sample Collected : Feb 13, 2026, 07:16 AM Report Date : Feb 13, 2026, 02:47 PM.
Test Description Value(s) Unit(s) Reference Range
of end organ damage 3. CHD stage 3B or 4. 4 LDL >190 mg/dl 5. Extreme of a single
High Risk
risk factor 6. Coronary Artery Calcium - CAC > 300 AU 7. Lipoprotein a >/= 50 mg/dl
8. Non stenotic carotid plaque
Moderate Risk 2 major ASCVD risk factors
Low Risk 0-1 major ASCVD risk factors
Major ASCVD (Atherosclerotic cardiovascular disease) Risk Factors
1. Age >/=45 years in Males &
3. Current Cigarette smoking or tobacco use
>/= 55 years in Females
2. Family history of premature
4. High blood pressure
ASCVD
5. Low HDL

Newer treatment goals and statin initiation thresholds based on the risk categories proposed by Lipid Association of India
in 2020.

Risk Group Treatment Goals Consider Drug Therapy

LDL-C (mg/dl) Non-HDL (mg/dl) LDL-C (mg/dl) Non-HDL (mg/dl)

Extreme Risk Group Category A <50 (Optional goal <OR = 30) <80 (Optional goal <OR = 60) >OR = 50 >OR = 80
Extreme Risk Group Category B >OR = 30 >OR = 60 > 30 > 60
Very High Risk <50 <80 >OR = 50 >OR = 80
High Risk <70 <100 >OR = 70 >OR = 100
Moderate Risk <100 <130 >OR = 100 >OR = 130
Low Risk <100 <130 >OR = 130* >OR = 160

* After an adequate non-pharmacological intervention for at least 3 months.

References : Management of Dyslipidaemia for the Prevention of Stroke : Clinical practice Recommendations from the Lipid Association of
India. Current Vascular Pharmacology,2022,20,134-155.

Note :- (H* - High , L* - Low ,CL* - Critical Low,CH* - Critical High)

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Seva Pathology, 12/475, Ultra Tower, Macrobert Ganj, Near Shani
Dev Mandir, Kanpur (UP)

Page 9 of 15
 Patient NAME : Mr Suresh Chandra Verma
DOB/Age/Gender : 60 Y/Male Report STATUS : Final Report
Patient ID / UHID : 15501765/RCL15402454 Barcode NO : 30363599
Referred BY : Self Sample Type : Serum
....

Sample Collected : Feb 13, 2026, 07:16 AM Report Date : Feb 13, 2026, 02:47 PM.
Test Description Value(s) Unit(s) Reference Range

Iron Studies

Iron 61.8 L* µg/dL 65 - 175

Ferene
TIBC,(Total Iron Binding Capacity) 278 µg/dL 250 - 450
Calculated
UIBC 216.2 µg/dL 69 - 240
Ferene
Transferrin Saturation 22.23 % 14 - 50
Method :Derived from IRON and TIBC values

Interpretation:
Increased levels due to iron ingestion or ineffective [Link] levels due to infection, inflammation, malignancy, menstruation and Fe [Link]
to be taken into consideration with TIBC. Transferrin Saturation:- Low level Transferrin Saturation can indicate iron deficiency, erythropoiesis, infection, or
inflammation. High level Transferrin Saturation can indicate recent ingestion of dietary iron,ineffective erythropoiesis,haemochromatosis or liver [Link] TIBC,
UIBC, or transferrin usually indicates iron deficiency, but they are also increased in pregnancy and with the use of oral contraceptives. Low TIBC, UIBC, or transferrin
may occur if someone has:Hemochromatosis, Certain types of anemia due to accumulated iron,Malnutrition,kidney disease that causes a loss of protein in urine.

Note :- (H* - High , L* - Low ,CL* - Critical Low,CH* - Critical High)

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Seva Pathology, 12/475, Ultra Tower, Macrobert Ganj, Near Shani
Dev Mandir, Kanpur (UP)

Page 10 of 15
 Patient NAME : Mr Suresh Chandra Verma
DOB/Age/Gender : 60 Y/Male Report STATUS : Final Report
Patient ID / UHID : 15501765/RCL15402454 Barcode NO : 30363599
Referred BY : Self Sample Type : Serum
....

Sample Collected : Feb 13, 2026, 07:16 AM Report Date : Feb 13, 2026, 02:28 PM.
Test Description Value(s) Unit(s) Reference Range

Vitamin D 25 Hydroxy

Vitamin D 25 - Hydroxy 24.32 L* ng/mL Deficient <20

CMIA Insufficient 21 - 29
Sufficient 30 - 100

Interpretation:
25-Hydroxy vitamin D represents the main body reservoir and transport form. Mild to moderate deficiency is associated with Osteoporosis /
Secondary Hyperparathyroidism while severe deficiency causes Rickets in children and Osteomalacia in adults. Prevalence of Vitamin D
deficiency is approximately >50% specially in the elderly. This assay is useful for diagnosis of vitamin D deficiency and Hypervitaminosis D. It
is also used for differential diagnosis of causes of Rickets & Osteomalacia and for monitoring Vitamin D replacement therapy.

Note :- (H* - High , L* - Low ,CL* - Critical Low,CH* - Critical High)

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Seva Pathology, 12/475, Ultra Tower, Macrobert Ganj, Near Shani
Dev Mandir, Kanpur (UP)

Page 11 of 15
 Patient NAME : Mr Suresh Chandra Verma
DOB/Age/Gender : 60 Y/Male Report STATUS : Final Report
Patient ID / UHID : 15501765/RCL15402454 Barcode NO : 30363599
Referred BY : Self Sample Type : Serum
....

Sample Collected : Feb 13, 2026, 07:16 AM Report Date : Feb 13, 2026, 02:28 PM.
Test Description Value(s) Unit(s) Reference Range

Thyroid Profile Total

Triiodothyronine (T3) 1.28 ng/ml 0.71 - 2.01

CMIA
Total Thyroxine (T4) 9.37 µg/dL 4.87 - 11.2
CMIA
Thyroid Stimulating Hormone (Ultrasensitive) 3.62 mIU/L 0.35 - 4.94
CMIA

Interpretation:
Pregnancy Refrence Range TSH
1st Trimester 0 .1 - 2.5
2nd Trimester 0.2 - 3.0
3rd Trimester 0.3 - 3.0

Clinical Use:
1. Diagnose Hypothyroidism & Hyperthyroidism
2. Monitor T4 therapy
3. Measure subnormal TSH levels

Increased TSH: Primary hypothyroidism, Subclinical hypothyroidism, TSH-dependent hyperthyroidism, Thyroid hormone resistance
Decreased TSH: Graves’ disease, Autonomous thyroid hormone secretion, TSH deficiency

Thyroid malfunction (hyper or hypo) affects T3 & T4 levels. Pituitary or hypothalamic issues also influence thyroid activity.

1. Primary Hypothyroidism: High TSH levels.

2. Secondary/Tertiary Hypothyroidism: Low TSH levels.
3. Euthyroid Sick Syndrome: Abnormal thyroid test results due to non-thyroidal illnesses (NTI).

TBG levels are stable in healthy individuals but may be altered by pregnancy, estrogens, androgens, steroids, or glucocorticoids, causing inaccurate T3 & T4
readings.

TSH T4 T3 Interpretation
High Normal Normal Mild (subclinical) hypothyroidism
High Low Low Or Nomral Hypothyroidism
Low Normal Normal Mild (subclinical) hyperthyroidism
Low High Or Normal High Or Normal Hyperthyroidism
Low Low Or Normal Low Or Normal Nonthyroidal illness; pituitary (secondary) hypothyroidism
Thyroid hormone resistance syndrome (a mutation in the thyroid hormone
Normal High High
receptor decreases thyroid hormone function)

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Seva Pathology, 12/475, Ultra Tower, Macrobert Ganj, Near Shani
Dev Mandir, Kanpur (UP)

Page 12 of 15
 Patient NAME : Mr Suresh Chandra Verma
DOB/Age/Gender : 60 Y/Male Report STATUS : Final Report
Patient ID / UHID : 15501765/RCL15402454 Barcode NO : 30363599
Referred BY : Self Sample Type : Serum
Sample Collected : Feb 13, 2026, 07:16 AM Report Date : Feb 13, 2026, 02:28 PM.
Test Description Value(s) Unit(s) Reference Range

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Seva Pathology, 12/475, Ultra Tower, Macrobert Ganj, Near Shani
Dev Mandir, Kanpur (UP)

Page 13 of 15
 Patient NAME : Mr Suresh Chandra Verma
DOB/Age/Gender : 60 Y/Male Report STATUS : Final Report
Patient ID / UHID : 15501765/RCL15402454 Barcode NO : 30335269
Referred BY : Self Sample Type : Spot Urine
....

Sample Collected : Feb 13, 2026, 07:16 AM Report Date : Feb 13, 2026, 03:10 PM.
Test Description Value(s) Unit(s) Reference Range

Urine Routine and Microscopic Examination

Physical Examination
Volume * 20 mL -
Colour * Pale yellow - Pale yellow
Transparency * Clear - Clear
Deposit * Absent - Absent
Chemical Examination
Reaction (pH) 6.0 - 4.5 - 8.0
Double Indicator
Specific Gravity 1.015 - 1.010 - 1.030
Ion Exchange
Urine Glucose (sugar) Negative - Negative
Urine Protein (Albumin) Negative - Negative
Urine Ketones (Acetone) Negative - Negative
Blood Negative - Negative
Leucocyte esterase Negative - Negative
Bilirubin Urine Negative - Negative
Nitrite Negative - Negative
Griless Test
Urobilinogen Normal - Normal
Ehrlichs Test
Microscopic Examination
Pus Cells (WBCs) * 1-2 /hpf 0-5
Epithelial Cells * 1-2 /hpf 0-4
Red blood Cells * Absent /hpf Absent
Crystals * Absent - Absent
Cast * Absent - Absent
Yeast Cells * Absent - Absent
Amorphous deposits * Absent - Absent
Bacteria * Absent - Absent
Protozoa * Absent - Absent

Interpretation:
URINALYSIS- Routine urine analysis assists in screening and diagnosis of various metabolic, urological, kidney and liver disorders.

Protein: Elevated proteins can be an early sign of kidney disease. Urinary protein excretion can also be temporarily elevated by strenuous
exercise, orthostatic proteinuria, dehydration, urinary tract infections and acute illness with fever

Glucose: Uncontrolled diabetes mellitus can lead to presence of glucose in urine. Other causes include pregnancy, hormonal disturbances,
liver disease and certain medications.

Ketones: Uncontrolled diabetes mellitus can lead to presence of ketones in urine. Ketones can also be seen in starvation, frequent vomiting,
pregnancy and strenuous exercise.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Seva Pathology, 12/475, Ultra Tower, Macrobert Ganj, Near Shani
Dev Mandir, Kanpur (UP)

Page 14 of 15
 Patient NAME : Mr Suresh Chandra Verma
DOB/Age/Gender : 60 Y/Male Report STATUS : Final Report
Patient ID / UHID : 15501765/RCL15402454 Barcode NO : 30335269
Referred BY : Self Sample Type : Spot Urine
Sample Collected : Feb 13, 2026, 07:16 AM Report Date : Feb 13, 2026, 03:10 PM.
Test Description Value(s) Unit(s) Reference Range

Blood: Occult blood can occur in urine as intact erythrocytes or haemoglobin, which can occur in various urological, nephrological and
bleeding disorders.

Leukocytes: An increase in leukocytes is an indication of inflammation in urinary tract or kidneys. Most common cause is bacterial urinary tract
infection.

Nitrite: Many bacteria give positive results when their number is high. Nitrite concentration during infection increases with length of time the
urine specimen is retained in bladder prior to collection.

pH: The kidneys play an important role in maintaining acid base balance of the body. Conditions of the body producing acidosis/ alkalosis or
ingestion of certain type of food can affect the pH of urine.

Specific gravity: Specific gravity gives an indication of how concentrated the urine is. Increased specific gravity is seen in conditions like
dehydration, glycosuria and proteinuria while decreased specific gravity is seen in excessive fluid intake, renal failure and diabetes insipidus.

Bilirubin: In certain liver diseases such as biliary obstruction or hepatitis, bilirubin gets excreted in urine.

Urobilinogen: Positive results are seen in liver diseases like hepatitis and cirrhosis and in cases of haemolytic anaemia.

*** End Of Report ***

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., C/O Seva Pathology, 12/475, Ultra Tower, Macrobert Ganj, Near Shani
Dev Mandir, Kanpur (UP)

Page 15 of 15
 Terms and Conditions of Reporting

1. The presented findings in the Reports are intended solely for informational and interpretational purposes by the
referring physician or other qualified medical professionals possessing a comprehensive understanding of
reporting units, reference ranges, and technological limitations. The laboratory shall not be held liable for any
interpretation or misinterpretation of the results, nor for any consequential or incidental damages arising from
such interpretation.

2. It is to be presumed that the tests performed pertain to the specimen/sample attributed to the Customer's name
or identification. It is presumed that the verification particulars have been cleared out by the customer or his/her
representation at the point of generation of said specimen / sample. It is hereby clarified that the reports
furnished are restricted solely to the given specimen only.

3. It is to be noted that variations in results may occur between different laboratories and over time, even for the
same parameter for the same Customer. The assays are performed and conducted in accordance with standard
procedures, and the reported outcomes are contingent on the specific individual assay methods and equipment(s)
used, as well as the quality of the received specimen.

4. This report shall not be deemed valid or admissible for any medico-legal purposes.

5. The Customers assume full responsibility for apprising the Company of any factors that may impact the test
finding. These factors, among others, includes dietary intake, alcohol, or medication / drug(s) consumption, or
fasting. This list of factors is only representative and not exhaustive.
SMART HEALTH REPORT

About Redcliffe Labs

We are India’s Most Trusted & Fastest Growing Network of Diagnostics Labs
Best Customer 100% Best Prices With
Experience Report Correctness Fast Reports

Commitment to excellence, Focus on quality with Value for money with

high end technology oriented staff accurate results quick turn around time (TAT)

Your booking just gave back to nature –

with every health checkup, you’re contributing by planting a tree!

Select from a wide range of

Full Body Health Check-up
packages that suits your health

Best Selling Package

Annual Health Checkup

Advance Plus with Free HsCRP

Get free report consultation

& download our app

A Simple and easy way to track your health

3600 + Tests & Packages Presence in 220+ Cities

45 Min Express Sample 100% Accurate Report

Collection Guarantee.